Oncology Times - Latest Articles

Oncology Times - Latest Articles
Biomarker of Aggressive Childhood Cancer Discovered

Researchers discovered a new diagnostic marker that distinguishes a fast-growing type of the pediatric brain cancer medulloblastoma from a less-aggressive type.

Oncology Times - Latest Articles
Ovarian Cancer Cells Cooperate to Metastasize

The team isolated subpopulations of cells from human ovarian tumors and found that none had the ability to form metastatic tumors on its own. 

Oncology Times - Latest Articles
FOCR Meeting Highlights Modernization of Expedited FDA Drug Approvals

The Friends of Cancer Research held the first of a two-part virtual annual meeting, which focused on ways of updating expedited drug approvals at the FDA.

Oncology Times - Latest Articles
Early Salvage Radiotherapy Bests Adjuvant Treatment for Prostate Cancer

Adjuvant radiotherapy following radical prostatectomy does not improve event-free survival in men with localized or locally advanced prostate cancer and should not be considered...

Oncology Times - Latest Articles
A New Strategy in Treating Patients With CAR T-Cell Therapy

A novel “switchable” CAR T-cell therapy for blood cancers moved into early clinical trials recently after gaining Fast Track designation from the FDA. 

Oncology Times - Latest Articles
New Study Confirms Pandemic's Harmful Effects on Cancer Care

A new study shows that the COVID-19 pandemic has resulted in major declines in cancer screening, diagnosis, and treatment of American seniors and Medicare beneficiaries in 2020.

Oncology Times - Latest Articles
The Role of Regular Mammograms in Finding Interval Breast Cancer

Strategies beyond current mammographic screening practices are needed to reduce incidence, improve detection, and reduce deaths from interval breast cancers...

Oncology Times - Latest Articles
Potential New Standard for High-Risk B-Cell Non-Hodgkin Lymphoma

DLBCL accounts for more than 60 percent of pediatric NHLs. Patients diagnosed with it have a 5-year survival rate of 63 percent for all disease stages combined.

Oncology Times - Latest Articles
FDA Approval of Immunotherapy Drugs Brings Hope to Mesothelioma Patients

The drugs—nivolumab and ipilimumab—have now been approved by the FDA for first-line treatment of adult patients who suffer from malignant pleural mesothelioma.

Oncology Times - Latest Articles
SABR Continues to Demonstrate Favorability Across Cancer Types

Data from a number of clinical trials presented at the ASTRO 2020 Annual Meeting continued to fortify earlier findings that demonstrated the benefits of SABR in treating patients...

Oncology Times - Latest Articles
Subscribe to Oncology Times - Latest Articles

source list reference